[go: up one dir, main page]

NL7700785A - Biologisch actieve peptiden ter vervanging van morfine. - Google Patents

Biologisch actieve peptiden ter vervanging van morfine.

Info

Publication number
NL7700785A
NL7700785A NL7700785A NL7700785A NL7700785A NL 7700785 A NL7700785 A NL 7700785A NL 7700785 A NL7700785 A NL 7700785A NL 7700785 A NL7700785 A NL 7700785A NL 7700785 A NL7700785 A NL 7700785A
Authority
NL
Netherlands
Prior art keywords
morphine
replacement
biologically active
active peptides
peptides
Prior art date
Application number
NL7700785A
Other languages
English (en)
Dutch (nl)
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB2900/76A external-priority patent/GB1577114A/en
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of NL7700785A publication Critical patent/NL7700785A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1016Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/70Enkephalins
    • C07K14/702Enkephalins with at least 1 amino acid in D-form
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • C07K5/0804Tripeptides with the first amino acid being neutral and aliphatic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NL7700785A 1976-01-26 1977-01-26 Biologisch actieve peptiden ter vervanging van morfine. NL7700785A (nl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB2900/76A GB1577114A (en) 1976-01-26 1976-01-26 Biologically active peptides
GB848176 1976-03-03
GB4882176 1976-11-23

Publications (1)

Publication Number Publication Date
NL7700785A true NL7700785A (nl) 1977-07-28

Family

ID=27254145

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7700785A NL7700785A (nl) 1976-01-26 1977-01-26 Biologisch actieve peptiden ter vervanging van morfine.

Country Status (11)

Country Link
JP (1) JPS5291839A (de)
CH (1) CH644352A5 (de)
DE (1) DE2703109A1 (de)
DK (1) DK33177A (de)
ES (1) ES455365A1 (de)
FI (1) FI70228C (de)
FR (1) FR2338925A1 (de)
HU (1) HU184704B (de)
IL (1) IL51332A (de)
NL (1) NL7700785A (de)
SE (1) SE7708404L (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4003000A (en) * 1975-05-27 1977-01-11 Sperry Rand Corporation Sinusoidal oscillator with electronically variable frequency
US4261888A (en) * 1976-04-12 1981-04-14 Sandoz Ltd. Organic compounds
FR2359817A1 (fr) * 1976-07-27 1978-02-24 Reckitt & Colmann Prod Ltd Nouveaux peptides, leur procede de preparation et composition therapeutique les contenant
GB1532148A (en) * 1976-08-09 1978-11-15 Searle & Co 1-substituted enkepholin derivatives
HU178001B (en) * 1976-09-16 1982-02-28 Gyogyszekutato Intezet Process for preparing new pentapeptides with morphine-like activity and derivatives thereof
DE2819277A1 (de) * 1977-05-16 1978-11-23 Sandoz Ag Neue polypeptidderivate, ihre herstellung und verwendung
GB2000784B (en) * 1977-07-05 1982-01-20 American Home Prod Analgesic polypetide
IT1107551B (it) * 1977-07-22 1985-11-25 Wellcome Found Pentapeptidi utili come medicamenti nella medicina umana e veterinaria e composizioni farmaceutiche che li contengono coem ingrediente attivo
US4264491A (en) * 1977-10-03 1981-04-28 Eli Lilly And Company Analgesic compounds
HU182051B (en) * 1978-05-02 1983-12-28 Takeda Chemical Industries Ltd Process for preparing tetrapeptide-hydrazyde derivatives
US4278596A (en) * 1978-08-08 1981-07-14 American Home Products Corporation Analgesic pentapeptides
CA1175810A (en) * 1979-03-30 1984-10-09 Frank A. Momany Synthetic peptides having pituitary growth hormone releasing activity
US4247543A (en) * 1979-04-09 1981-01-27 Sandoz Ltd. Organic compounds
US4396606A (en) * 1979-11-05 1983-08-02 Addiction Research Foundation Novel polypeptide analgesics
EP0044451B1 (de) * 1980-07-17 1984-04-18 Sandoz Ag Pentapeptide, Verfahren zu deren Herstellung, deren pharmazeutische Zusammensetzungen und deren Anwendung
FR2488253A1 (fr) * 1980-08-08 1982-02-12 Roques Bernard Nouveaux peptides et leur application en therapeutique
BR8208035A (pt) * 1981-12-28 1983-11-22 Beckman Instruments Inc Peptideos sinteticos tendo atividade liberadora de hormonio do crescimento da pituitaria
US4491541A (en) * 1982-11-10 1985-01-01 Farmitalia Carlo Erba Peptides
JPH0680079B2 (ja) * 1984-11-09 1994-10-12 エーザイ株式会社 ポリペプチド
AU618029B2 (en) * 1987-11-02 1991-12-12 Imperial Chemical Industries Plc Polypeptide compounds
JPH07503485A (ja) * 1992-11-12 1995-04-13 バイオメジャー インコーポレイテッド オピオイドペプチド
AU2010236730B2 (en) * 2009-04-13 2012-09-20 Elc Management Llc Methionine sulfoxide peptide, compositions and methods of use
WO2019051494A1 (en) 2017-09-11 2019-03-14 Protagonist Therapeutics, Inc. OPIOID AGONIST PEPTIDES AND USES THEREOF

Also Published As

Publication number Publication date
FI70228B (fi) 1986-02-28
FI770254A7 (de) 1977-07-27
IL51332A (en) 1980-09-16
FI70228C (fi) 1986-09-15
ES455365A1 (es) 1978-05-16
DE2703109A1 (de) 1977-08-04
JPS5291839A (en) 1977-08-02
IL51332A0 (en) 1977-03-31
HU184704B (en) 1984-10-29
CH644352A5 (en) 1984-07-31
DK33177A (da) 1977-07-27
SE7708404L (sv) 1977-07-27
FR2338925A1 (fr) 1977-08-19
FR2338925B1 (de) 1980-08-08

Similar Documents

Publication Publication Date Title
NL7700785A (nl) Biologisch actieve peptiden ter vervanging van morfine.
IT8024755A0 (it) Nuovi peptidi biologicamente attivi.
NL7704150A (nl) Werkwijze voor het bereiden van peptiden met gonadoliberine-werking.
NL7707689A (nl) Elektrodenstelsel.
SG76083G (en) Peptides
EG12845A (en) Delivery means for biologically active agents
NL7709147A (nl) Verbeteringen betreffende transporteurs.
IT8321093A0 (it) Peptidi.
NL7812166A (nl) Peptiden.
AU513702B2 (en) Peptides
GB1556984A (en) Time base correcting system
MY8500260A (en) Biologically active peptides
NO764050L (no) System for vekststoette.
FI813198A7 (fi) Menetelmä farmakologisesti aktiivisten peptidien valmistamiseksi.
AU504317B2 (en) Phychopharmacologically active peptides
JPS539761A (en) Peptide derivative
NL7702028A (nl) Bronpunten-systeem.
FI772512A7 (fi) Biologiskt aktiva foereningar
IT8026673A0 (it) Peptidi farmacologicamente attivi.
NL7607683A (nl) Werkwijze ter bereiding van nieuwe peptiden en peptide-derivaten en de toepassing hiervan.
JPS5697256A (en) Pharmacutically active peptides
NL7708225A (nl) Werkwijze voor de bereiding van peptiden.
NL7707781A (nl) Psychofarmacologische peptiden.
FI773213A7 (fi) Biologiskt aktiva foereningar
IT1212790B (it) Peptidi biologicamente attivi.

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
A85 Still pending on 85-01-01
BV The patent application has lapsed